🎆2026 https://t.co/5xo7LSIrN4 New Year Airdrop🎉
Snag your slice of 10,000 $ANB rewards by finishing a few quick tasks:
🔶Connect your X account and follow @ant_fun_trade
🔶Retweet our post
🔶Make your first trade on Web (0 fees!) or in the App
🔶Invite friends and earn extra bonuses
Event ends in 15 days, check the details on the event page.
Join now: https://t.co/YgHTiUmKnk
Fully Local Wallet Control + Multi-Chain All-in-One + Zero Platform Fee = Your Future Trading!
✨Nexira’s New Year Campaign is officially live.
Easy quests, nice rewards, stacking Ruby 🚀
Join now 👉 https://t.co/JlGNnUcrHH
#Nexira#NewYearCampaign#NexiraDAEP#NexiraSeason1
https://t.co/TcBYa4TVng
✨ Nexira New Year’s Airdrop Campaign is OPEN — A fresh start with big rewards!
Kickstart 2026 with exclusive bonuses and limited-time loot to fuel your journey.
✅ Complete simple tasks
🎁 Claim your Boxes
💎 Massive 50M Ruby Rewards convertible to $NEXI at TGE
🔥 Join now: https://t.co/IeVIGsk1sM
📖 Full details: https://t.co/35BhdedHaF
#Nexira #Airdrop #Web3Gaming #Ruby
@SoSoValueCrypto
SoSoValueCrypto highlights the rise of decentralized finance (DeFi) as a powerful alternative to traditional banking. It gives users global access to lending, borrowing, and trading without intermediaries.
@SoSoValueCrypto
Markets move because of money flow. SoSoValueCrypto tracks where the big money is going — from whales to institutions. Instead of reacting late, you’ll know the move before the crowd does.
One #BioDAO project a day! @MycoDAO@BioProtocol
The image looks familiar 🤣🤣🤣
@MycoDAO is a DAO-driven global platform aimed at accelerating fungal research, innovation, and environmental restoration via decentralized science.
Their mission: unlock fungi’s potential for biotech, health, sustainability, and materials by funding research, enabling community participation, and tokenizing intellectual property.
1. Key Features & Initiatives
1.1 Research Focus Areas:
- Bioremediation: using fungi to reduce heavy metals/pollutants, degrade waste, etc.
- Production of bioactive compounds, sustainable biomaterials.
- Education and scholarship support for budding mycologists.
1.2. Infrastructure & Access:
- “Lab-in-a-Box”: portable, modular labs (possibly in containers) so remote communities or under-served regions can conduct fungal science without needing heavy fixed infrastructure.
- Franchise labs and tools for local researchers and citizen scientists.
1.3. Token / Value Capture Model:
- They have a token called MYCO. Token gives governance rights, staking, participation incentives.
- IP tokenization: DNA sequences, fungal strains might be tokenized so that fractional ownership or licensing revenue is shared.
1.4. Roadmap
- Q1-2025: Launch via @BioProtocol Launchpad; begin trials (Project Oyster); start scholarship funding (NANA); etc.
- Q3-2025: Build labs, report findings, fund education, etc.
2. Strengths
- Novel / underserved research domain: Fungus biology / mycology often under-funded; big potential in bio-compounds, environmental remediation, new materials.
- Community + Citizen Science: By involving local researchers, amateurs, remote areas, the DAO model can bring more data, biodiversity mapping, etc.
- Accessibility: Lab-in-a-Box and franchise labs reduce barriers to entry for research globally.
- Tokenization & Governance: MYCO token, IP tokenization add incentive alignment; users not just passive investors but can influence and participate.
- Environmental / Social Impact: Bioremediation, sustainability, education—high “mission” value.
3. Opportunities:
- Huge potential value in discovering novel fungal compounds (pharmaceuticals, enzymes, biodegradable materials, etc).
- Environmental remediation (pollution, heavy metals) is a pressing global need; fungi are a promising tool.
- Growing interest in sustainable materials and alternatives to plastics etc could favor the biomaterials side.
- Citizen science and distributed research might unlock biodiversity data, new species etc.
- Tokenization / DeSci models are increasingly popular; early movers may benefit from network effects.
"MycoDAO is a very promising project, particularly for those excited about DeSci, environment, biotech, materials. If execution, funding, and regulatory / IP strategy go well, it could deliver both impact and upside."
One #BioDAO project a day! @D1ckDAO@D1ckGPT@BioProtocol
The project is expected to launch this week! 💰
D1ckDAO is a project focused on improving men’s sexual health. It aims to build a decentralized community (a DAO) where scientists and members collaborate on solutions for issues that often are underserved, stigmatized, or ignored: erectile dysfunction (ED), hormonal imbalance (e.g. low testosterone), premature ejaculation, etc.
They plan to do more than sell “quick fix” products; instead they emphasize real science, clinically validated bioactive compounds, trials, better delivery methods, cognitive enhancement tied to hormonal health, etc.
D1ckDAO presents as an ambitious, somewhat novel project that seeks to bridge Web3 / DAO structure + scientific research + men’s health solutions. There is clear potential: underserved market, real needs, opportunity for impact. If well-executed, it could carve a niche.
🛰️Fresh out of KBW2025, we are excited to share a roadmap reveal: Starmesh, the Virtual Satellite Network (VSN) that gives you the privacy and safety you deserve when accessing the Internet.
While we build out our broader physical satellite internet infra, you'll first be able to use Starmesh to browse the web with ultra privacy, and tap into decentralized services like data storage on @WalrusProtocol and DeFi on @Creditcoin
One #BioDAO project a day! @DalyaDAO@BioProtocol@DalyaDAO is a DAO / BioDAO operating under the @BioProtocol / #DeSci (Decentralized Science) paradigm. Its mission is to address neglected diseases — diseases that primarily impact low-income countries and are typically under-served by big pharmaceutical R&D.
1. Key components of Dalya’s approach:
- Digital biology: they plan to leverage advanced computational tools (like molecular modelling, biosimulation) to screen therapeutic targets, design novel compounds, and repurpose existing drugs.
- Advanced disease modeling: using more human-relevant systems like organ-on-chip and human tissue models for better predictive validity.
- Cataloguing prior work: Dalya intends to collect and organize datasets, early-stage compounds, and targets that have previously been researched but abandoned because of low commercial incentive.
2. Several strengths highlight the potential of DalyaDAO.
- Clear unmet need:
Neglected diseases represent a major global health burden. The data Dalya provides shows that many diseases causing high disability in the poorest regions receive almost no drug development. Addressing this gap has high social value.
- Use of modern computational and modeling tools:
By using in silico screening, advanced modeling, repurposing, etc., Dalya can reduce upfront cost, accelerate candidate discovery, and potentially improve success rates, compared to traditional drug discovery that begins mostly in wet labs.
- Transparency & open science ethos:
The model of BioProtocol and related DeSci efforts implies more openness: making datasets, targets, early findings publicly available, licensing that allows use and follow-on research. This can help build community trust and perhaps attract collaborators (academia, NGOs).
- Phased roadmap:
Having a multi-phase roadmap (2025-2027) gives structure and potentially allows assessment of progress over time. Early outcomes (public health analysis, establishing databases, partner networks) are achievable and can signal legitimacy.
Overall, DalyaDAO looks like a promising, socially relevant initiative. The combination of computational biology, open science, and focus on neglected diseases gives it both moral appeal and potential scientific leverage.
One #BioDAO project a day! @endrarediseases@BioProtocol
Curetopia is a #BioDAO (Decentralized Autonomous Organization focused on biotech) whose mission is to eradicate rare genetic diseases by enabling on-chain governance, community participation, and drug repurposing, especially using model organisms (yeast) to accelerate discovery.
1. The main highlights of the project are as follows:
- It aims to serve patient communities, researchers, and DeSci (decentralized science) enthusiasts.
- The DAO uses a governance token, $CURES, giving utility & voting rights, as well as rewarding contributions (data, clinical participation, etc.).
- Curetopia positions itself as an alternative to traditional pharmaceutical and venture capital-driven biotech, which tends to neglect rare diseases due to small markets, fragmented patient populations, and risk/return profiles
2. Scientific / Operational Approach:
- Drug repurposing is the flagship strategy: screening existing drugs, nutraceuticals, over-the-counter compounds for new uses in rare/inherited metabolic diseases (IMDs).
- Use of yeast “avatars”: modifying yeast genes (or using ancestral versions of human disease genes) to model disease mutations. Yeast is chosen because of its well‐studied genetics, fast growth, and cost-effectiveness.
- After screening, promising candidates are tested further (e.g. in clinical settings, or with patient families) in “1-to-N” trials (starting with a pioneer patient/family then expanding) to generate real-world evidence.
@endrarediseases is an ambitious attempt to combine #DeSci, community governance, biotechnology, and patient-driven research to address a major unmet need: rare diseases. Its approach—drug repurposing + model organisms + token-governed funding & IP—is promising, especially given the huge cost and time of developing new drugs from scratch.
If its scientific pipelines deliver hits that translate, and if regulatory, governance, and funding/logistics risks are managed carefully, it could become a meaningful new model for biotech, particularly for rare diseases.
One #BioDAO project a day! @psy_dao@BioProtocol@psy_dao is a decentralized autonomous organization (DAO) focused on advancing psychedelic research, culture, and community. Its mission is to build a new funding and governance infrastructure for psychedelic science, where knowledge, data, and intellectual property (IP) are openly shared and fairly rewarded.
With a treasury of around $2M and grants already distributed to early-stage projects, PsyDAO positions itself at the intersection of mental health innovation, Web3 governance, and scientific decentralization.
Strengths of PsyDAO:
1️⃣ Clear vision in a high-potential domain
Psychedelics are gaining traction as potential therapies for depression, PTSD, and mental health disorders. PsyDAO enters this space at a time when decentralized funding and governance can play a key role in accelerating responsible research.
2️⃣ DAO-based grant funding
Through initiatives like Alchemist Grants, PsyDAO enables the community to decide which research and cultural projects should be funded. This creates transparency and democratizes access to capital in a field often limited by traditional institutions.
3️⃣ Open IP and tokenized data
Projects like OPSY and IP-NFTs focus on incentivized data collection, ensuring contributors are rewarded while maintaining openness. This aligns well with the DeSci ethos of turning data into a collective asset rather than siloed IP.
4️⃣ Cultural + scientific fusion
By funding not only research but also art and cultural initiatives, PsyDAO strengthens community engagement and expands beyond academia into real-world impact.
@psy_dao fits naturally into the DeSci ecosystem. By combining its psychedelic-focused mission with platforms like @BioProtocol , the following synergies emerge:
- Funding integration: BioProtocol’s launchpad could channel liquidity into PsyDAO’s psychedelic trials.
- Data governance: Shared frameworks for decentralized data (DKG, IP-NFTs) enhance cross-project interoperability.
- Community overlap: Both target global researchers, clinicians, and crypto-native users who believe in science as a public good.
If successful, PsyDAO could accelerate access to safe psychedelic therapies, pioneer tokenized data models, and demonstrate how decentralized governance can transform one of the most controversial yet promising fields in modern medicine.